4//SEC Filing
CAUWENBERGH GEERT 4
Accession 0001209191-23-011926
CIK 0001533040other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 7:15 PM ET
Size
5.1 KB
Accession
0001209191-23-011926
Insider Transaction Report
Form 4
CAUWENBERGH GEERT
DirectorPresident & CEO
Transactions
- Award
Common stock, $0.0001 par value
2023-02-17+1,500→ 4,235 total
Footnotes (2)
- [F1]Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date.
- [F2]Includes shares of common stock underlying unvested restricted stock units. Effective as of 12:01 a.m. Eastern Time on January 26, 2023, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-12.
Documents
Issuer
Phio Pharmaceuticals Corp.
CIK 0001533040
Entity typeother
Related Parties
1- filerCIK 0001285648
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 7:15 PM ET
- Size
- 5.1 KB